Pharvaris (PHVS) Reports Q3 Results After Phase 3 Milestone
Pharvaris reported third-quarter 2026 financial results and said it is preparing for a potential first commercial launch. The release cites a successful pivotal Phase 3 readout for deucrictibant XR; it provides no financial figures.Material DetailsContext by AI AnalystThe release presents a late-st…